Semi-Annual Consolidated Statement Of Cash Flows

COSMOS Pharmaceutical Corporation - Filing #7545326

Concept As at
2023-05-31
2022-06-01 to
2023-05-31
2021-06-01 to
2022-05-31
As at
2022-05-31
As at
2021-05-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
63,475,000,000 JPY
45,382,000,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-51,000,000 JPY
-52,000,000 JPY
Income taxes paid
-9,111,000,000 JPY
-13,337,000,000 JPY
Net cash provided by (used in) operating activities
54,434,000,000 JPY
32,194,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-46,636,000,000 JPY
-43,497,000,000 JPY
Proceeds from sale of property, plant and equipment
46,000,000 JPY
1,519,000,000 JPY
Other, net
-958,000,000 JPY
-915,000,000 JPY
Net cash provided by (used in) investing activities
-49,113,000,000 JPY
-43,717,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
10,000,000,000 JPY
300,000,000 JPY
Repayments of long-term borrowings
-1,628,000,000 JPY
-1,486,000,000 JPY
Purchase of treasury shares
0 JPY
-2,000,000 JPY
Dividends paid
-3,266,000,000 JPY
-3,266,000,000 JPY
Net cash provided by (used in) financing activities
3,245,000,000 JPY
-6,222,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
8,566,000,000 JPY
-17,745,000,000 JPY
Cash and cash equivalents
45,928,000,000 JPY
37,362,000,000 JPY
55,108,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.